Skip to main content

Pharsight, Sanofi-Synthelabo Ink PKS Deal

NEW YORK, Sept. 26 - Pharsight today said French biotech company Sanofi-Synthelabo Recherche will use its Knowledgebase software for drug discovery.


The deal is the third in two months for the Mountain View, Calif., company: Over two weeks in August Pharsight penned similar deals with Organon and Schering-Plough.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.